Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ATHA | Athira Pharma, Inc. | Gengos Andrew | CFO AND CHIEF BUSINESS OFFICER | Jan 05, 2024 | Sale | $2.91 | 1,208 | 3,515 | 83,804 | Feb 16, 2024, 04:34 PM | |
ATHA | Athira Pharma, Inc. | Gengos Andrew | See Below | Jan 05, 2023 | Sale | $2.91 | 1,208 | 3,515 | 83,804 | Jan 08, 2024, 04:42 PM | |
ATHA | Athira Pharma, Inc. | Gengos Andrew | See Below | Jun 07, 2023 | Buy | $3.43 | 15,000 | 51,445 | 80,012 | Jun 09, 2023, 05:06 PM | |
ATHA | Athira Pharma, Inc. | Gengos Andrew | See Below | Jun 02, 2023 | Buy | $2.82 | 20,012 | 56,422 | 20,012 | Jun 06, 2023, 07:36 PM | |
ATHA | Athira Pharma, Inc. | Gengos Andrew | See Below | Jun 05, 2023 | Buy | $3.00 | 45,000 | 135,150 | 65,012 | Jun 06, 2023, 07:36 PM | |
IMUC | ImmunoCellular Therapeutics, Ltd. | Gengos Andrew | Director | Dec 31, 2016 | Option Exercise | $2.05 | 3,284 | 6,732 | 5,249 | Feb 13, 2017, 04:04 PM | |
IMUC | ImmunoCellular Therapeutics, Ltd. | Gengos Andrew | President and CEO | Nov 30, 2015 | Buy | $0.44 | 10,000 | 4,350 | 47,000 | Dec 02, 2015, 07:43 PM | |
IMUC | ImmunoCellular Therapeutics, Ltd. | Gengos Andrew | President and CEO | Feb 18, 2015 | Buy | $0.60 | 41,333 | 24,800 | 78,333 | Feb 20, 2015, 06:36 PM | |
IMUC | ImmunoCellular Therapeutics, Ltd. | Gengos Andrew | President and CEO | Aug 14, 2014 | Buy | $0.90 | 10,000 | 8,994 | 37,000 | Aug 14, 2014, 05:38 PM | |
IMUC | ImmunoCellular Therapeutics, Ltd. | Gengos Andrew | President and CEO | Dec 18, 2013 | Buy | $0.72 | 27,000 | 19,362 | 27,000 | Dec 18, 2013, 12:49 PM |